Weed, Inc. (BUDZ): Operating Cash Flow
-$195.1K
Year ended 2025-12-31
-$201.1K
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$195.1K | n/m | 2026-04-08, From 2025-01-01 |
| 2024-12-31 | -$415.5K | n/m | 2026-04-08, From 2024-01-01 |
| 2023-12-31 | -$1.07M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$813.0K | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$568.9K | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$431.0K | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$1.11M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$3.18M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$670.2K | n/a | 2019-04-16, From 2017-01-01 |
| No annual figure between 2011-12-31 and 2017-12-31. | |||
| 2011-12-31 | -$123.7K | n/m | 2012-04-16, From 2011-01-01 |
| 2010-12-31 | -$139.6K | n/a | 2012-04-16, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Weed, Inc. (BUDZ) | 2025-12-31 | -$195.1K | n/m |
| NRC Health (NRC) | 2025-12-31 | $26.45M | -23.6% |
| Incyte Corp (INCY) | 2025-12-31 | $1.41B | +321.5% |
| Icon PLC (ICLR) | 2025-12-31 | $1.04B | -19.5% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $737.65M | +0.4% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$34.41M | n/m |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | -$329.6K | n/m |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $2.65B | -2.3% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | -$4.24M | n/m |
Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗